Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Amoxapine & dipyridamole
(D00302)
2件: Amoxapine,
Dipyridamole
2件: Amoxapine ,
Dipyridamole (D00302) 💬
4件: PDE4A,
PDE5A,
SLC6A2,
SLC6A4 💬
8件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, Serotonergic synapse, Synaptic vesicle cycle, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 46 💬
2Dipyridamole
(D00302)
1件: Dipyridamole1件: Dipyridamole (D00302) 💬2件: PDE4A,
PDE5A 💬
6件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬6件: 46, 49, 51, 66, 96, 224 💬
3Dipyridamole and Amoxapine
(D00302)
2件: Amoxapine,
Dipyridamole
2件: Amoxapine ,
Dipyridamole (D00302) 💬
4件: PDE4A,
PDE5A,
SLC6A2,
SLC6A4 💬
8件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, Serotonergic synapse, Synaptic vesicle cycle, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 46 💬
4Dipyridamole Tab 25 MG
(D00302)
1件: Dipyridamole1件: Dipyridamole (D00302) 💬2件: PDE4A,
PDE5A 💬
6件: Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 224 💬
5Extended release dipyridamole 200mg/aspirin 25mg
(D00302)
2件: Acetylsalicylic acid,
Dipyridamole
2件: Aspirin ,
Dipyridamole (D00302) 💬
4件: PDE4A,
PDE5A,
PTGS1,
PTGS2 💬
28件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Morphine addiction, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Purine metabolism, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 49 💬
6Prednisolone & dipyridamole
(D00302)
2件: Dipyridamole,
Prednisolone
2件: Dipyridamole (D00302),
Prednisolone 💬
3件: NR3C1,
PDE4A,
PDE5A 💬
7件: Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 46 💬
7Prednisolone-Dipyridamole
(D00302)
2件: Dipyridamole,
Prednisolone
2件: Dipyridamole (D00302),
Prednisolone 💬
3件: NR3C1,
PDE4A,
PDE5A 💬
7件: Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 46 💬
8Z102 (Prednisolone and Dipyridamole).
(D00302)
2件: Dipyridamole,
Prednisolone
2件: Dipyridamole (D00302),
Prednisolone 💬
3件: NR3C1,
PDE4A,
PDE5A 💬
7件: Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 46 💬